Last reviewed · How we verify
PHENDIMETRAZINE
At a glance
| Generic name | PHENDIMETRAZINE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1976 |
Approved indications
Common side effects
- elevated blood pressure
- psychotic state
- blurring of vision
- stomach pain
- dysuria
- changes in libido
- palpitation
- tachycardia
- overstimulation
- restlessness
- insomnia
- agitation
Key clinical trials
- A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy
- Evaluation of Periodontal Distractor in Acceleration of Canine Retraction (NA)
- Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars (EARLY_PHASE1)
- Reinforcing Effects of Cocaine During Phendimetrazine Maintenance (PHASE1)
- Phendimetrazine and Cocaine (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PHENDIMETRAZINE CI brief — competitive landscape report
- PHENDIMETRAZINE updates RSS · CI watch RSS